The development follows the commissioning of the hydroxyurea manufacturing facility by Quality Chemical Industries Limited (QCIL) in Luzira, Kampala, where the company also unveiled Sikurea, a locally produced hydroxyurea medicine used in the treatment of sickle cell disease.
